Webinar
High-Quality Vaccine Development Powered by Quality Control Using Agilent Fragment Analyzer System
On-Demand
Speaking at the Vaccine Research & Development 2022, Kyle Luttgeharm, PhD, Product Manager from Agilent presented their talk on IVT RNA production and
accurate and precise mRNA analysis.
accurate and precise mRNA analysis.
Webinar
Looking to the Future of Cell and Gene Therapies
On-Demand
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Webinar
Innovative Strategies for Therapeutic Antibody Development and Production
On-Demand
This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.
Webinar
The "What" and "Why" of mRNA Production
On-Demand
The popularity of mRNA-based therapeutics continues to grow as their ability to express the target of interest continues to improve. The challenge that scientists now face is how to scale up production to make these novel therapeutics available for use.
Webinar
Plan Now or Fail Later: Why Raw Materials Matter
On-Demand
Accelerating the development of mRNA vaccines and therapeutics requires the selection and use of raw materials designed to meet critical process, scale, quality and regulatory needs. Choosing appropriate materials saves scientists both time and money.
Webinar
The Most Comprehensive Insights in Cancer Genomes: Translational Research
On-Demand
This symposium brings together world-leading experts in cancer research and translational medicine to showcase how nanopore sequencing technology is being utilized to identify novel disease biomarkers.
From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.
The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.
From the characterization of small biomarkers, like circulating tumor DNA and single-nucleotide variants, to large structural variants and base modifications, nanopore sequencing delivers comprehensive insights into the cancer genome.
The speakers will discuss targeted and genome-wide detection of circulating tumor DNA, exploration of brain tumors and sarcomas and how nanopore sequencing has advanced their research.
Advertisement